Skip to content
Back to Guavy Wire
Stocks

Amgen Expands in Telangana with Genome Valley Innovation Centre

Instruments
AMGN
Share

Amgen, a global biotechnology leader, is setting up an innovation centre at Genome Valley in Hyderabad. The state-of-the-art Research and Innovation Centre will further strengthen Telangana's position as a leading destination for life sciences research and innovation.

Amgen India signed a Memorandum of Understanding (MoU) with the government of Telangana, which was witnessed by IT & Industries Minister Duddilla Sridhar Babu. This marks Amgen's continued expansion in Hyderabad, where it has already established a major Global Capability Centre (GCC) with around 3,000 employees.

The proposed Research and Innovation Centre at Genome Valley is expected to create employment opportunities for highly skilled professionals and add momentum to Hyderabad's emergence as a global hub for advanced life sciences research. Telangana Minister Sridhar Babu welcomed the development, highlighting the state's growing confidence in its talent pool, infrastructure, and innovation ecosystem.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc